Euronext Paris Growth Leaders With High Insider Stakes May 2024

In this article:

Amid a backdrop of rising optimism in European markets, with France's CAC 40 Index recently climbing by 3.29%, investors are closely watching the potential for policy easing and its implications on market dynamics. In such a context, companies with high insider ownership can be particularly noteworthy, as they often signal strong confidence from those most familiar with the company's inner workings and future prospects.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

VusionGroup (ENXTPA:VU)

13.3%

25.8%

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

24.8%

37.7%

WALLIX GROUP (ENXTPA:ALLIX)

19.9%

101.4%

La Française de l'Energie (ENXTPA:FDE)

20.1%

37.6%

OSE Immunotherapeutics (ENXTPA:OSE)

25.1%

92.9%

Adocia (ENXTPA:ADOC)

12.9%

104.5%

Icape Holding (ENXTPA:ALICA)

30.2%

30%

Arcure (ENXTPA:ALCUR)

21.6%

41.7%

Munic (ENXTPA:ALMUN)

29.2%

150%

MedinCell (ENXTPA:MEDCL)

16.6%

68.8%

Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company that specializes in developing long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €428.37 million.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €14.13 million.

Insider Ownership: 16.6%

Revenue Growth Forecast: 40.9% p.a.

MedinCell, a French biotech firm, has demonstrated significant growth potential with its innovative long-acting injectable technologies. Recently, MedinCell announced promising results from a Phase 3 trial of TEV-‘749 for schizophrenia and a lucrative partnership with AbbVie potentially worth up to US$1.9 billion in milestones plus royalties. Despite high revenue growth forecasts (40.9% per year) and nearing profitability within three years, shareholder dilution occurred last year and the stock price remains volatile.

ENXTPA:MEDCL Ownership Breakdown as at May 2024
ENXTPA:MEDCL Ownership Breakdown as at May 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. offers a range of cloud services and hosting solutions globally, with a market capitalization of approximately €1.16 billion.

Operations: The company generates revenue primarily through three segments: Public Cloud (€140.71 million), Private Cloud (€514.59 million), and Web cloud (€179.45 million).

Insider Ownership: 10.5%

Revenue Growth Forecast: 11.3% p.a.

OVH Groupe, a French cloud services provider, is expected to transition into profitability within the next three years with anticipated earnings growth of 101.5% annually. This growth is supported by revenue increases projected at 11.3% per year, outpacing the French market's average of 5.8%. However, its return on equity is forecasted to remain low at 3.8%. Recent strategic hires and expansion into new markets like Canada highlight its commitment to innovation and international growth despite a highly volatile share price in recent months.

ENXTPA:OVH Ownership Breakdown as at May 2024
ENXTPA:OVH Ownership Breakdown as at May 2024

VusionGroup

Simply Wall St Growth Rating: ★★★★★★

Overview: VusionGroup S.A. is a company that offers digitalization solutions for commerce across Europe, Asia, and North America, with a market capitalization of approximately €2.50 billion.

Operations: The firm specializes in providing digitalization services across three key regions: Europe, Asia, and North America.

Insider Ownership: 13.3%

Revenue Growth Forecast: 24.3% p.a.

VusionGroup S.A. has demonstrated robust financial performance with a significant increase in yearly sales to €801.96 million and net income soaring to €79.77 million, reflecting strong operational execution. The company's earnings per share also showed substantial growth. Forecasted revenue and earnings growth outpace the French market, expected at 24.3% and 25.8% per year respectively, indicating potential for continued expansion. However, the stock is characterized by high volatility, presenting a risk factor despite no substantial insider selling detected recently.

ENXTPA:VU Ownership Breakdown as at May 2024
ENXTPA:VU Ownership Breakdown as at May 2024

Next Steps

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTPA:MEDCL ENXTPA:OVH and ENXTPA:VU.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Advertisement